N. Morisaki et al., Glycosylative inactivation of chalcomycin and tylosin by a clinically isolated Nocardia asteroides strain, J ANTIBIOT, 54(2), 2001, pp. 157-165
Studies on the susceptibility of pathogenic Nocardia to macrolide antibioti
cs, chalcomycin and tylosin, showed that most of the Nocardia species exami
ned were highly resistant to both antibiotics, although N. nova was moderat
ely susceptible. N. asteroides IFM 0339 converted these macrolides into ina
ctive metabolites by glycosylation at 2'-OH or glycosylation and reduction
of the 20-formyl group. The structures of the metabolites were determined f
rom NMR and MS data to be 2'-[O-(beta -D-glucopyranosyl)]chalcomycin (2), 2
'-[O-(beta -D-glucopyranosyl)]tylosin (5) and 20-dihydro-2'-[O-(beta -D-glu
copyranosyl)]tylosin (4).